Key facts
- It has raised $580K; the latest was Secondary Transaction - Private in Jul 2024.
- Notable investors include X&, Aniruddha Malpani, TrueTribe VC, Vida Ventures (India).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for RedBook
- ·The full record, as it builds
Funding rounds
No funding rounds for RedBook are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RedBook
Developer of pharmacy software designed to offer insights into drug consumption patterns, streamline administrative tasks, and increase productivity. The company's platform includes features like distributor integration, online ordering, offline synchronization, stock expiry notifications, and micro-level insights on customers, enabling companies to market their products through pharmacies, track sales in real-time, and seamlessly integrate the healthcare ecosystem.
- Sector
- Information Technology
- HQ
- Mumbai, India
- Founded
- 2015
- Employees
- 87
- Website
- redbook.co.in/
- Ownership
- Privately Held (backing)
RedBook doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RedBook shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RedBook in its N-PORT filings yet. We sweep new filings monthly.